Mirae Asset Global ETFs Holdings
ABEO icon

Mirae Asset Global ETFs Holdings’s Abeona Therapeutics ABEO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93K Buy
20,760
+518
+3% +$2.59K ﹤0.01% 2704
2025
Q4 		$107K Sell
20,242
-241
-1% -$1.21K ﹤0.01% 2644
2025
Q3 		$108K Sell
20,483
-3,423
-14% -$21.7K ﹤0.01% 2623
2025
Q2 		$136K Buy
+23,906
New +$136K ﹤0.01% 2454

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ABEO Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Abeona Therapeutics (ABEO) stake by 2.6% in Q1 2026, buying an estimated $2.59K and bringing the position to 20,760 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #2704.

Mirae Asset Global ETFs Holdings first reported a position in ABEO in Q2 2025 and has held it in 4 quarters since. The position peaked at $136K in Q2 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 20,760 shares of Abeona Therapeutics worth $93K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 518 Abeona Therapeutics shares in Q1 2026, an estimated $2.59K.
  • Abeona Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2704 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Mirae Asset Global ETFs Holdings's Abeona Therapeutics position peaked at $136K in Q2 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.